HIGHLIGHTS
- who: Alexandra L. G. Mahoney and collaborators from the School of Life Sciences, University of Technology Sydney, Sydney, Australia have published the research: Pancreatic Transdifferentiation Using -Cell Transcription Factors for Type 1 Diabetes Treatment, in the Journal: Cells 2022, 11, 2145. of 16/05/2022
- what: Type 1 diabetes (T1D) results from the T-cell-mediated destruction of insulin-producing u03b2-cells in the pancreas and is the focus of this review .
SUMMARY
Currently, there is significant research into initiating transdifferentiation of both stem_cells and somatic_cells through either in_vitro or in_vivo . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.